Scottish university reveals multimillion-pound Parkinson’s research partnership

News

Author: Roisin McCormackPublished: 10 July 2019

Prep: Cook: Serves:

Doctor analysing patient brain scan results

The University of Dundee, UK, has announced a collaboration with South Korean pharmaceutical company Bukwang to develop a new treatment for Parkinson’s.

Collaborating with researchers at the University of Oxford, UK, the university’s drug discovery unit (DDU) has found molecules that may reduce levels of a protein closely connected to the development of the condition.

The new partnership will build on this existing relationship between the universities – and facilitate a further three-year Parkinson’s research programme which will move the molecules towards clinical development.

Professor Paul Wyatt, head of the DDU, said: “Drug discovery for neurological disorders is especially challenging and an area where academia and industry need to be working together.

“This project brings together the clinical and translational research expertise in Oxford with Dundee’s professional drug-discovery capabilities, allowing us to move one stage further towards a treatment.”

To read more on this topic click here.

Acupuncture may alleviate Parkinson’s symptoms

Last Month

Next Month

Go Back

Share this story

Comments

Interviews

Alison Anderson: the “cyclopath”

We spoke to the campaigner who cycled 1,000 miles

“My next adventure is to concentrate on living”

Robin Buttery: the man behind the 3,600-mile Indian Ocean row

When will new Parkinson’s psychosis drug be approved outside of the US?

FDA approves drug to treat hallucinations and delusions

Scotland sees soaring Parkinson’s rate

The number of drugs being prescribed for people living with Parkinson’s in Scotland, UK, has increased by more than a quarter. National Health Service (NHS) figures, published by the Scottish Conservative party, show that the number of items being dispensed for the condition have leapt by 28% – from 260,355 in 2010 to 333,167 in 2019. The sharp rise is thought to be a consequence of Scotland’s ageing population and has prompted calls from bodies, including Parkinson’s UK, for government action to ensure the NHS can cope with the increasing number of Parkinson’s cases. Annie Macleod, director of Parkinson’s UK Scotland, said: “Over the next decade we expect to see numbers increase by a fifth.” She added that reasons for such a spike could include “growing numbers of people living with more complex Parkinson’s, or changes to the ways that specialists are managing Parkinson’s”.

Over a quarter of people living with Parkinson’s were initially misdiagnosed, study finds

More than a quarter of people living with Parkinson’s were initially misdiagnosed, according to new research from charity Parkinson’s UK. As part of the study, 2,000 people with Parkinson’s were asked a series of questions about their diagnosis. According to results, 26% of the participants were originally told they did not have Parkinson’s – with almost half of them being treated for a different condition. The poll also found that women were more likely to be misdiagnosed than men. Katie Goates, professional engagement manager at Parkinson’s UK, said: “One of the biggest challenges for Parkinson’s research is that there is no definitive test for Parkinson’s, and as a result we’ve heard of people being misdiagnosed with anything from a frozen shoulder or anxiety to a stroke. “Our survey has shown that because of this people are being left in limbo and seeing their health deteriorate, which is unacceptable.”

Queen Elizabeth II honours UK university for Parkinson’s research

A neuroscience research centre at the University of Sheffield, UK, has been recognised by Queen Elizabeth II for improving the lives of patients living with neurodegenerative conditions, including Parkinson’s. The Sheffield Institute for Translational Neuroscience, which is based at the university, uses emerging developments in neuroscience to create innovative new approaches to treating brain conditions. The prestigious Queen’s Anniversary Prize was awarded at St James’s Palace, London. The institute was commended for its development of Parkinson’s drug discovery programmes. The honour is awarded to UK universities who exhibit groundbreaking and innovative approaches to research – with beneficial results at local, national and global levels. Professor Koen Lamberts, president and vice-chancellor for the University of Sheffield, said: “As well as making life-changing discoveries today, The Sheffield Institute for Translational Neuroscience is nurturing the next generation of talented neuroscience students, whose research will lead to pioneering treatments for those living with neurological…

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Comments
This field is for validation purposes and should be left unchanged.

Scottish university reveals multimillion-pound Parkinson’s research partnership

News

Author: Roisin McCormackPublished: 10 July 2019

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Interviews

Alison Anderson: the “cyclopath”

Interviews

“My next adventure is to concentrate on living”

Advances

When will new Parkinson’s psychosis drug be approved outside of the US?

Scotland sees soaring Parkinson’s rate

Over a quarter of people living with Parkinson’s were initially misdiagnosed, study finds

Queen Elizabeth II honours UK university for Parkinson’s research

{title}

Subscribe

Scottish university reveals multimillion-pound Parkinson’s research partnership

News

Author: Roisin McCormackPublished: 10 July 2019

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

Interviews

Alison Anderson: the “cyclopath”

Interviews

“My next adventure is to concentrate on living”

Advances

When will new Parkinson’s psychosis drug be approved outside of the US?

Scotland sees soaring Parkinson’s rate

Over a quarter of people living with Parkinson’s were initially misdiagnosed, study finds

Queen Elizabeth II honours UK university for Parkinson’s research

{title}

Subscribe

Sign in